Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Local Envafolimab + Chemotherapy in NSCLC
NCT06108726Phase 2Unknown
- Sponsor
- Subei People's Hospital
- Start
- Oct 2023
- Primary completion
- Jan 2025
- Modality
- Nanobodies (VHH), Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of envafolimab in non-small cell lung cancer (NSCLC), sponsored by Subei People's Hospital. Status: unknown.
02
Drugs
envafolimab
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT06108726.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06108726.